Stage IVB Rectal Cancer Completed Phase 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00077298Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal CancerTreatment